Emerging Therapies for Blood Cancer Patients: Highlights from the ASH Meeting
Every December the American Society of Hematology (ASH) meets to discuss the latest results from clinical trials for blood cancer patients. The Leukemia & Lymphoma Society (LLS) is pleased to bring this year's groundbreaking information to Northern California patients and their caregivers. New this year is an afternoon program for myeloma patients and their caregivers, "Tools for Self Care: Through Myeloma Treatment and Beyond."
ASH is a free educational program, but space is limited and registration is required. To reserve your space, please complete the online registration form below. For more information call us at (866) 450-0669.
If you would like to make a donation to support our mission to find a cure for leukemia, lymphoma, Hodgkin's disease and myeloma and improve the quality of life for patients and their families, please click here.
Saturday, January 23, 2010
Hilton San Francisco Union Square
333 O'Farrell Street, San Francisco
9:00 a.m. - 12:30 p.m. Emerging Therapies for Blood Cancer Patients
1:00 p.m. - 3:15 p.m. Tools for Self Care: Through Myeloma Treatment and Beyond
Morning session will include breakfast at 9:00 a.m.
Afternoon session will include lunch at 1:00 p.m.
Morning Program Agenda
9:00 a.m. Arrival and Breakfast Served
9:30 a.m. Keynote Address
A Researcher's Perspective on The Leukemia & Lymphoma Society:
Beverly Mitchell, M.D., George E. Becker Professor of Medicine; Director, Stanford Cancer Center
10:30 a.m. Concurrent Breakout Sessions
Chronic lymphocytic leukemia: Steven Coutré, M.D.,
Associate Professor of Medicine, Division of Hematology, Stanford
Chronic myelogenous leukemia: Neil Shah, M.D., Ph.D.,
Assistant Professor, Division of Hematology/Oncology, UCSF
Non-Hodgkin lymphoma (High Grade/Aggressive): Lawrence D. Kaplan, M.D., Clinical Professor of Medicine; Director, Adult Lymphoma Program, UCSF
Non-Hodgkin lymphoma (Low Grade/Indolent) & Waldenstrom's:
C. Babis Andreadis, M.D., MSCE, Assistant Clinical Professor of Medicine, UCSF
Myeloma: Jeffrey Wolf, M.D.,
Clinical Professor of Medicine and Director of the Myeloma Program, UCSF
Myelodysplastic Syndromes: Thomas Martin, M.D.,
Clinical Professor of Medicine, UCSF
Afternoon Program Agenda